HPC (Cord Blood, Duke University School of Medicine)

N/A

Report date: 2026/01/19 16:37:12

Base Information

Drug NameHPC (Cord Blood, Duke University School of Medicine)
Drug Alias Name造血祖细胞（脐带血）(Duke University School of Medicine)脐带血造血祖细胞 (Cord Blood, Duke University School of Medicine)Ducord
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord blood-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsHematopoietic stem cell transplantation (HSCT)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/10/04
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDuke University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesClinimmune Labs
Inactive CompaniesN/A
Active IndicationsHematopoietic stem cell transplantation (HSCT)
Inactive IndicationsN/A

Other Information

ATC CodeB05AX04
Related LinksN/A